Replies to post #27049 on Seelos Therapeutics Inc (SEEL)

[OldtimeramI]

Do not know what he is talking about. I did spend 20 - 30 minutes skimming through the exhibits that come with the Sec filing. But at first glance came up empty.

Not sure if he is just trying to justify his decision. As you can see from my posts, I am not behind what he just did. If he went down this road - pointing to possible future Vitaros liabilities in Europe - hopefully he addresses this during the conference call. Although - if he does this - he might just tip his cards in regards to any possible problems that might be run into ( in the future ) here in the United States.

I will have time to go over the filings with detail, as that is something I intend to do before I decide to invest my money back into this company. Doubt it will be before the end of May though, as the NDA resubmission will be Q3 2017 ( and going by Apricus' past timeframes - that means September 30, 2017 - note: painful memories surface ). While the NASDAQ situation must be remedied by May 30, 2017.

O.T.

I saw your earlier post regarding Bassam Damaj. I am sure you know he is still wheeling and dealing over there at Innovus Pharma. Still buying products ( now big into OTC products ) with shares - left and right. Once in a while I look at what he is doing over there. Never have bought a single share. He has some very creative accounting over there. Talk about P.R. spins.

Last I looked - he has around 125 million shares outstanding and has promised many more to many people. When he took over - there were no more than 16 million shares outstanding. I am sure he would love the opportunity of a back door listing. Which is exactly the term for the type of situation that I was talking about earlier.

This also takes me to my point regarding not being able to access cash easily when you trade on the pink sheets. Take a look at Innovus and compare to Apricus.

One last thing. Don't you find it ironic that he has one million in shareholder equity ( trying real hard not to laugh )? Just has to cook the books to show 5 million in intangible assets to be able to show this.

Good luck

[OldtimeramI]

Mean gene

As the days have gone by, it has occurred to me of a possibility in regards to the ex-U.S. - He might be talking about the $1.5 m that was owed to Sandoz. Apricus was to start paying quarterly payments of $300,000 starting in Q2 2017 to Sandoz. Hopefully this is what he is talking about. Although I don't know why he wouldn't just state this in the press release. It would actually make his sell price look a little better.

If this is the case, the stockholders equity would be affected positively by that same amount. We would still be short $1 m to $1.5 m up until the end of February.

Good luck tomorrow!